Beneficiaries and Associate Partners |
Lead |
|---|---|
| University of Oslo, Norway | Yuichi Mori |
| Oslo University Hospital, Norway | Michael Bretthauer |
| MAGIC Evidence Ecosystem Foundation, Norway | Per Olav Vandvik |
| Aarhus University, Denmark | Rune Erichsen |
| Karolinska Institute, Sweden | Johannes Blom |
| Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Poland | Michal F. Kaminski |
| Fundació Clínic per a la Recerca Biomèdica and Hospital Clinic de Barcelona, Spain | Maria Pellisé |
| Humanitas University, Italy | Cesare Hassan |
| University Hospital Eppendorf, Germany | Thomas Rosch |
| National and Kapodistrian University of Athens, Greece | Konstantinos Triantafyllou |
| King's College Hospital NHS Foundation Trust, United Kingdom | Shraddha Gulati |
| University College London, United Kingdom | Omer Ahmad |
| Maplesoft Europe Limited, United Kingdom | Juergen Gerhard |
| Beth Israel Deaconess Medical Center, INC Non-profit Corporation, USA | Tyler M. Berzin |
| University of Illinois Urbana-Champaign, USA | Sara Gerke |
| Showa University, Japan | Shin-ei Kudo |
| Nagoya University, Japan | Kensaku Mori |
Partners
The OperA project cosists of 17 partners with world-class expertise in gastroenterology, machine learning, cancer screening, biostatistics, disease modelling, regulatory science, and ethics and law in medicine.
Published May 12, 2022 1:28 PM
- Last modified Apr. 24, 2025 2:05 PM